Plasma IL-6 and IL-10 levels in visceral leishmaniasis (VL) patients during clinical follow up.

(A) IL-6 and (C) IL-10 levels were analyzed in the active phase and one-month post-treatment (1 mpt) in VL patients and in healthy volunteers. (B and D) The insert shows the IL-6 and IL-10 levels from the same patients prospectively evaluated in two different time points (n = 22). Each symbol represents one patient. The horizontal bar represents the median values. Asterisks denote a statistically significant difference between groups, *p<0.05; **p<0.01.